Artículos de revistas sobre el tema "Peptide LL-37"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Peptide LL-37".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Nagant, C., B. Pitts, K. Nazmi, M. Vandenbranden, J. G. Bolscher, P. S. Stewart y J. P. Dehaye. "Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments". Antimicrobial Agents and Chemotherapy 56, n.º 11 (20 de agosto de 2012): 5698–708. http://dx.doi.org/10.1128/aac.00918-12.
Sieprawska-Lupa, Magdalena, Piotr Mydel, Katarzyna Krawczyk, Kinga Wójcik, Magdalena Puklo, Boguslaw Lupa, Piotr Suder et al. "Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases". Antimicrobial Agents and Chemotherapy 48, n.º 12 (diciembre de 2004): 4673–79. http://dx.doi.org/10.1128/aac.48.12.4673-4679.2004.
Perez-Perez, David A., Teresa de J. Villanueva-Ramirez, Adriana E. Hernandez-Pedraza, Nestor G. Casillas-Vega, Patricia Gonzalez-Barranco y Xristo Zarate. "The Small Metal-Binding Protein SmbP Simplifies the Recombinant Expression and Purification of the Antimicrobial Peptide LL-37". Antibiotics 10, n.º 10 (19 de octubre de 2021): 1271. http://dx.doi.org/10.3390/antibiotics10101271.
Sigurdardottir, Thorgerdur, Pia Andersson, Mina Davoudi, Martin Malmsten, Artur Schmidtchen y Mikael Bodelsson. "In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37". Antimicrobial Agents and Chemotherapy 50, n.º 9 (septiembre de 2006): 2983–89. http://dx.doi.org/10.1128/aac.01583-05.
Yang, De, Qian Chen, Albert P. Schmidt, G. Mark Anderson, Ji Ming Wang, Joseph Wooters, Joost J. Oppenheim y Oleg Chertov. "Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells". Journal of Experimental Medicine 192, n.º 7 (2 de octubre de 2000): 1069–74. http://dx.doi.org/10.1084/jem.192.7.1069.
Rinker, Sherri D., Michael P. Trombley, Xiaoping Gu, Kate R. Fortney y Margaret E. Bauer. "Deletion ofmtrCin Haemophilus ducreyi Increases Sensitivity to Human Antimicrobial Peptides and Activates the CpxRA Regulon". Infection and Immunity 79, n.º 6 (28 de marzo de 2011): 2324–34. http://dx.doi.org/10.1128/iai.01316-10.
Zhang, Yingxia, Jayaram Lakshmaiah Narayana, Qianhui Wu, Xiangli Dang y Guangshun Wang. "Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37". Pharmaceuticals 14, n.º 12 (30 de noviembre de 2021): 1245. http://dx.doi.org/10.3390/ph14121245.
Yason, John Anthony, Sitara Swarna Rao Ajjampur y Kevin Shyong Wei Tan. "Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37". Infection and Immunity 84, n.º 8 (23 de mayo de 2016): 2220–32. http://dx.doi.org/10.1128/iai.00339-16.
Amagai, Ryo, Toshiya Takahashi, Hitoshi Terui, Taku Fujimura, Kenshi Yamasaki, Setsuya Aiba y Yoshihide Asano. "The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors". International Journal of Molecular Sciences 24, n.º 1 (3 de enero de 2023): 875. http://dx.doi.org/10.3390/ijms24010875.
Mirzaee, Malihe, Edita Holásková, Alžbeta Mičúchová, David J. Kopečný, Zhila Osmani y Ivo Frébort. "Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants". Antibiotics 10, n.º 8 (23 de julio de 2021): 898. http://dx.doi.org/10.3390/antibiotics10080898.
Chawla, Himika, Parmita Kar, Soma Saha, Urvashi B. Singh, Nikhil Tandon y Goswami R. "Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control". Annals of the National Academy of Medical Sciences (India) 53, n.º 02 (abril de 2017): 066–72. http://dx.doi.org/10.1055/s-0040-1712747.
Turner, Jeffrey, Yoon Cho, Nhu-Nguyen Dinh, Alan J. Waring y Robert I. Lehrer. "Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils". Antimicrobial Agents and Chemotherapy 42, n.º 9 (1 de septiembre de 1998): 2206–14. http://dx.doi.org/10.1128/aac.42.9.2206.
Hase, Koji, Lars Eckmann, John D. Leopard, Nissi Varki y Martin F. Kagnoff. "Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium". Infection and Immunity 70, n.º 2 (febrero de 2002): 953–063. http://dx.doi.org/10.1128/iai.70.2.953-963.2002.
Guo, Fang-Fang y Jing-Yuan Fang. "Antimicrobial peptide LL-37 and gastrointestinal diseases". World Chinese Journal of Digestology 22, n.º 35 (2014): 5454. http://dx.doi.org/10.11569/wcjd.v22.i35.5454.
Bucki, Robert, Katarzyna Leszczyńska, Andrzej Namiot y Wojciech Sokołowski. "Cathelicidin LL-37: A Multitask Antimicrobial Peptide". Archivum Immunologiae et Therapiae Experimentalis 58, n.º 1 (5 de enero de 2010): 15–25. http://dx.doi.org/10.1007/s00005-009-0057-2.
Marr, A. K., S. Cen, R. E. W. Hancock y W. R. McMaster. "Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity". Antimicrobial Agents and Chemotherapy 60, n.º 4 (16 de febrero de 2016): 2484–91. http://dx.doi.org/10.1128/aac.02328-15.
Zhao, Chengquan, Tung Nguyen, Lee Ming Boo, Teresa Hong, Cesar Espiritu, Dmitri Orlov, Wei Wang, Alan Waring y Robert I. Lehrer. "RL-37, an Alpha-Helical Antimicrobial Peptide of the Rhesus Monkey". Antimicrobial Agents and Chemotherapy 45, n.º 10 (1 de octubre de 2001): 2695–702. http://dx.doi.org/10.1128/aac.45.10.2695-2702.2001.
Shaykhiev, Renat, Christoph Beißwenger, Kerstin Kändler, Judith Senske, Annette Püchner, Thomas Damm, Jürgen Behr y Robert Bals. "Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure". American Journal of Physiology-Lung Cellular and Molecular Physiology 289, n.º 5 (noviembre de 2005): L842—L848. http://dx.doi.org/10.1152/ajplung.00286.2004.
Sol, Asaf, Ofir Ginesin, Stella Chaushu, Laila Karra, Shunit Coppenhagen-Glazer, Isaac Ginsburg y Gilad Bachrach. "LL-37 Opsonizes and Inhibits Biofilm Formation of Aggregatibacter actinomycetemcomitans at Subbactericidal Concentrations". Infection and Immunity 81, n.º 10 (8 de julio de 2013): 3577–85. http://dx.doi.org/10.1128/iai.01288-12.
Gutner, Michal, Stella Chaushu, Daniela Balter y Gilad Bachrach. "Saliva Enables the Antimicrobial Activity of LL-37 in the Presence of Proteases of Porphyromonas gingivalis". Infection and Immunity 77, n.º 12 (5 de octubre de 2009): 5558–63. http://dx.doi.org/10.1128/iai.00648-09.
Rapala-Kozik, Maria, Oliwia Bochenska, Marcin Zawrotniak, Natalia Wolak, Grzegorz Trebacz, Mariusz Gogol, Dominika Ostrowska, Wataru Aoki, Mitsuyoshi Ueda y Andrzej Kozik. "Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans". Infection and Immunity 83, n.º 6 (6 de abril de 2015): 2518–30. http://dx.doi.org/10.1128/iai.00023-15.
Wang, Guangshun, Karen M. Watson y Robert W. Buckheit. "Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins". Antimicrobial Agents and Chemotherapy 52, n.º 9 (30 de junio de 2008): 3438–40. http://dx.doi.org/10.1128/aac.00452-08.
Kumagai, Yumi, Taisuke Murakami, Kuwahara-Arai, Toshiaki Iba, Johannes Reich y Isao Nagaoka. "Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils". Innate Immunity 26, n.º 7 (29 de junio de 2020): 565–79. http://dx.doi.org/10.1177/1753425920936754.
Rosen, Graciela, Michael N. Sela y Gilad Bachrach. "The Antibacterial Activity of LL-37 against Treponema denticola Is Dentilisin Protease Independent and Facilitated by the Major Outer Sheath Protein Virulence Factor". Infection and Immunity 80, n.º 3 (19 de diciembre de 2011): 1107–14. http://dx.doi.org/10.1128/iai.05903-11.
Johansson, Linda, Pontus Thulin, Parham Sendi, Erika Hertzén, Adam Linder, Per Åkesson, Donald E. Low, Birgitta Agerberth y Anna Norrby-Teglund. "Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans". Infection and Immunity 76, n.º 8 (19 de mayo de 2008): 3399–404. http://dx.doi.org/10.1128/iai.01392-07.
Yusuf, Muhammad, Wanda Destiarani, Ade Rizqi Ridwan Firdaus, Fauzian Giansyah Rohmatulloh, Mia Tria Novianti, Gita Widya Pradini y Reiva Farah Dwiyana. "Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by All-Atom Molecular Dynamics Simulation". International Journal of Molecular Sciences 23, n.º 21 (2 de noviembre de 2022): 13413. http://dx.doi.org/10.3390/ijms232113413.
OREN, Ziv, Jeffrey C. LERMAN, Gudmundur H. GUDMUNDSSON, Birgitta AGERBERTH y Yechiel SHAI. "Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity". Biochemical Journal 341, n.º 3 (26 de julio de 1999): 501–13. http://dx.doi.org/10.1042/bj3410501.
Bals, Robert, Xiaorong Wang, Michael Zasloff y James M. Wilson. "The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface". Proceedings of the National Academy of Sciences 95, n.º 16 (4 de agosto de 1998): 9541–46. http://dx.doi.org/10.1073/pnas.95.16.9541.
Jang, Yong-Suk, Sae-Hae Kim, Ha-Yan Lee, Jisang Park y Kyung-Yeol Lee. "Formyl-peptide receptor 2-expressing cells in Peyer’s patch are closely associated with the regulation of antigen-specific mucosal immune induction (MUC4P.832)". Journal of Immunology 192, n.º 1_Supplement (1 de mayo de 2014): 133.8. http://dx.doi.org/10.4049/jimmunol.192.supp.133.8.
Bryzek, Danuta, Anna Golda, Joanna Budziaszek, Dominik Kowalczyk, Alicia Wong, Ewa Bielecka, Priyanka Shakamuri et al. "Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity". International Journal of Molecular Sciences 21, n.º 23 (30 de noviembre de 2020): 9126. http://dx.doi.org/10.3390/ijms21239126.
Ciornei, Cristina D., Thorgerdur Sigurdardóttir, Artur Schmidtchen y Mikael Bodelsson. "Antimicrobial and Chemoattractant Activity, Lipopolysaccharide Neutralization, Cytotoxicity, and Inhibition by Serum of Analogs of Human Cathelicidin LL-37". Antimicrobial Agents and Chemotherapy 49, n.º 7 (julio de 2005): 2845–50. http://dx.doi.org/10.1128/aac.49.7.2845-2850.2005.
Ishvaanjil, Bayartbat, Yu-Jin Jung, Uyangaa Temuujin, Soon-Youl Lee y Kwon-Kyoo Kang. "HETEROLOGOUS EXPRESSION OF ANTIMICROBIAL PEPTIDE LL-37 IN CHINESE CABBAGE WITH ENHANCED RESISTANCE TO PATHOGENS". Mongolian Journal of Agricultural Sciences 13, n.º 2 (22 de junio de 2015): 124–30. http://dx.doi.org/10.5564/mjas.v13i2.531.
Zeth, Kornelius y Enea Sancho-Vaello. "Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures". International Journal of Molecular Sciences 22, n.º 10 (14 de mayo de 2021): 5200. http://dx.doi.org/10.3390/ijms22105200.
Torossian, Alexander, Eugeniu Gurschi, Robert Bals, Timon Vassiliou, Hinnerk F. Wulf y Artur Bauhofer. "Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats". Anesthesiology 107, n.º 3 (1 de septiembre de 2007): 437–41. http://dx.doi.org/10.1097/01.anes.0000278906.86815.eb.
Ridyard, Kylen E. y Joerg Overhage. "The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent". Antibiotics 10, n.º 6 (29 de mayo de 2021): 650. http://dx.doi.org/10.3390/antibiotics10060650.
Hitchon, Carol A., Xiaobo Meng, Hani S. El Gabalawy y Linda Larcombe. "Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis". RMD Open 5, n.º 1 (abril de 2019): e000874. http://dx.doi.org/10.1136/rmdopen-2018-000874.
Haisma, Elisabeth M., Anna de Breij, Heelam Chan, Jaap T. van Dissel, Jan W. Drijfhout, Pieter S. Hiemstra, Abdoelwaheb El Ghalbzouri y Peter H. Nibbering. "LL-37-Derived Peptides Eradicate Multidrug-Resistant Staphylococcus aureus from Thermally Wounded Human Skin Equivalents". Antimicrobial Agents and Chemotherapy 58, n.º 8 (19 de mayo de 2014): 4411–19. http://dx.doi.org/10.1128/aac.02554-14.
Mücke, Pierre-Alexander, Sandra Maaß, Thomas P. Kohler, Sven Hammerschmidt y Dörte Becher. "Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37". Microorganisms 8, n.º 3 (14 de marzo de 2020): 413. http://dx.doi.org/10.3390/microorganisms8030413.
Bachrach, G., G. Chaushu, M. Zigmond, E. Yefenof, A. Stabholz, J. Shapira, J. Merrick y S. Chaushu. "Salivary LL-37 Secretion in Individuals with Down Syndrome is Normal". Journal of Dental Research 85, n.º 10 (octubre de 2006): 933–36. http://dx.doi.org/10.1177/154405910608501012.
Byfield, Fitzroy J., Qi Wen, Katarzyna Leszczyńska, Alina Kułakowska, Zbigniew Namiot, Paul A. Janmey y Robert Bucki. "Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability". American Journal of Physiology-Cell Physiology 300, n.º 1 (enero de 2011): C105—C112. http://dx.doi.org/10.1152/ajpcell.00158.2010.
Bals, Robert, Daniel J. Weiner, A. David Moscioni, Rupalie L. Meegalla y James M. Wilson. "Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide". Infection and Immunity 67, n.º 11 (1 de noviembre de 1999): 6084–89. http://dx.doi.org/10.1128/iai.67.11.6084-6089.1999.
Martynowycz, Michael, Amy Rice, Konstantin Andreev, Thatyane M. Nobre Pavinatto, Jeff Wereszczynski y David Gidalevitz. "Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides". Biophysical Journal 116, n.º 3 (febrero de 2019): 45a. http://dx.doi.org/10.1016/j.bpj.2018.11.285.
McCrudden, Maelíosa, Katherine O’Donnell, Chris Irwin y Fionnuala Lundy. "Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?" Vaccines 6, n.º 3 (23 de julio de 2018): 44. http://dx.doi.org/10.3390/vaccines6030044.
Lysenko, Elena S., Jane Gould, Robert Bals, James M. Wilson y Jeffrey N. Weiser. "Bacterial Phosphorylcholine Decreases Susceptibility to the Antimicrobial Peptide LL-37/hCAP18 Expressed in the Upper Respiratory Tract". Infection and Immunity 68, n.º 3 (1 de marzo de 2000): 1664–71. http://dx.doi.org/10.1128/iai.68.3.1664-1671.2000.
Nagaoka, Isao, Satoko Hirota, François Niyonsaba, Michimasa Hirata, Yoshiyuki Adachi, Hiroshi Tamura, Shigenori Tanaka y Didier Heumann. "Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues". Clinical and Vaccine Immunology 9, n.º 5 (septiembre de 2002): 972–82. http://dx.doi.org/10.1128/cdli.9.5.972-982.2002.
Chung, Myung-Chul, Scott N. Dean y Monique L. van Hoek. "Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37". Biochemical Journal 470, n.º 2 (20 de agosto de 2015): 243–53. http://dx.doi.org/10.1042/bj20150432.
Deshpande, Dhruva, Mark Grieshober, Fanny Wondany, Fabian Gerbl, Reiner Noschka, Jens Michaelis y Steffen Stenger. "Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37". International Journal of Molecular Sciences 21, n.º 18 (14 de septiembre de 2020): 6741. http://dx.doi.org/10.3390/ijms21186741.
Lau, Y. Elaine, Annett Rozek, Monisha G. Scott, Danika L. Goosney, Donald J. Davidson y Robert E. W. Hancock. "Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells". Infection and Immunity 73, n.º 1 (enero de 2005): 583–91. http://dx.doi.org/10.1128/iai.73.1.583-591.2005.
Chen, Xi, Xianqiong Zou, Guangying Qi, Ying Tang, Yong Guo, Jia Si y Lihua Liang. "Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer". Cellular Physiology and Biochemistry 47, n.º 3 (2018): 1060–73. http://dx.doi.org/10.1159/000490183.
Noore, Jabeen, Adly Noore y Bingyun Li. "Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus". Antimicrobial Agents and Chemotherapy 57, n.º 3 (28 de diciembre de 2012): 1283–90. http://dx.doi.org/10.1128/aac.01650-12.